glucovance造句

• Analysts estimate Glucovance could generate annual sales of at least $ 900 million.
• Glucovance revenues plunged 86 percent to $ 13 million.
• Http : / / www . glucovance . com
• Glucovance revenues plunged 86 percent to $ 13 million ( euro10.2 million ).
• The most common side effects of Glucovance are usually diarrhea, nausea, and upset stomach.
• Squibb recently announced it is designing studies in children for its Glucovance, just approved last summer.
• It currently offers coupons for its diabetes treatments, Glucovance and the extended-release Glucophage XR.
• Patent losses dragged down sales of diabetes drug Glucovance as well as cancer treatments Taxol and Paraplatin.
• Bristol-Myers Squibb currently offers coupons for its diabetes treatments, Glucovance and the extended-release Glucophage XR.
• In rare cases, Glucovance may cause lactic acidosis, which can be fatal in up to half of the cases.
• Glucovance is a combination of another diabetes drug made by the company, Glucophage, and the generic diabetes pill glyburide.
• Bristol had been aggressively distributing free samples of the family of diabetes medications to introduce the recent extension of the line : Glucovance and Glucophage XR.
• The company did not conduct any tests of Glucovance against two newer diabetes drugs-- SmithKline Beecham's Avandia and Eli Lilly's Actos.
• Glucovance, which is a combination of Glucophage and a generic diabetes pill Metformin, is intended as a therapy for patients with Type 2 or adult onset diabetes.
• An Aug . 1 story on the Food and Drug Administration's approval of a new Bristol-Myers Squibb diabetes drug, Glucovance, incorrectly identified the drug's makeup.
• The U . S . Food and Drug Administration on Tuesday approved Bristol-Myers Squibb's new diabetes drug Glucovance, which may help patients control their blood sugar better than some existing pills.
• He even had to learn about Type 2 diabetes, since Bristol-Myers Squibb planned to use the Excedrin car in a new campaign that pushes the company's diabetes drugs Glucophage XR and Glucovance.
• A Bristol-Myers-funded study of 800 patients, presented at the American Diabetes Association meeting in June, found that Glucovance worked better at reducing patients blood sugar than either Glucophage or Metformin alone.
• Over two-thirds of the patients in the study who received Glucovance achieved ADA recommended blood sugar goals . " Glucovance represents a new approach to managing type 2 diabetes, " said Richard J . Lane, president of Bristol-Myers'worldwide medicines group . " It is our hope that the introduction of this novel agent could change the treatment paradigm for the more than 15 million patients in the U . S . with this condition ."
• Over two-thirds of the patients in the study who received Glucovance achieved ADA recommended blood sugar goals . " Glucovance represents a new approach to managing type 2 diabetes, " said Richard J . Lane, president of Bristol-Myers'worldwide medicines group . " It is our hope that the introduction of this novel agent could change the treatment paradigm for the more than 15 million patients in the U . S . with this condition ."